Report for Balayssac D

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial - Kerckhove_2022_BMC.Cancer_22_742
Author(s) : Kerckhove N , Tougeron D , Lepage C , Pezet D , Le Malicot K , Pelkowski M , Pereira B , Balayssac D
Ref : BMC Cancer , 22 :742 , 2022
Abstract : Kerckhove_2022_BMC.Cancer_22_742
ESTHER : Kerckhove_2022_BMC.Cancer_22_742
PubMedSearch : Kerckhove_2022_BMC.Cancer_22_742
PubMedID: 35799138

Title : Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors - Selvy_2022_Biomed.Pharmacother_149_112915
Author(s) : Selvy M , Mattevi C , Dalbos C , Aissouni Y , Chapuy E , Martin PY , Collin A , Richard D , Dumontet C , Busserolles J , Conde S , Balayssac D
Ref : Biomed Pharmacother , 149 :112915 , 2022
Abstract : Selvy_2022_Biomed.Pharmacother_149_112915
ESTHER : Selvy_2022_Biomed.Pharmacother_149_112915
PubMedSearch : Selvy_2022_Biomed.Pharmacother_149_112915
PubMedID: 35635358

Title : Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception - Ferrier_2015_J.Neurosci_35_16418
Author(s) : Ferrier J , Bayet-Robert M , Dalmann R , El Guerrab A , Aissouni Y , Graveron-Demilly D , Chalus M , Pinguet J , Eschalier A , Richard D , Daulhac L , Marchand F , Balayssac D
Ref : Journal of Neuroscience , 35 :16418 , 2015
Abstract : Ferrier_2015_J.Neurosci_35_16418
ESTHER : Ferrier_2015_J.Neurosci_35_16418
PubMedSearch : Ferrier_2015_J.Neurosci_35_16418
PubMedID: 26674867